Member Info for chrishutch

Where are you talking about Andy? I think the FTSE and AIM all share will close to flat mate.

Looks more positive...will she move back up.

Haha, we are not that silly.

It does look ready to turn up. Come on VAST

Hopefully made the right call.

With India, today, abandoning the requirement for testing prescriptions and encouraging a big testing drive. #ODX and its gold standard test are perfectly positioned to exploit this.

We did over 3 million in volume yesterday. So using that as metrix I would think the churn will be faster than you think, also no one is going to want to sell stock at a loss so the sells will likely be higher.

I think that could be very likely at the moment too! They are starting a big testing phase and ODX is perfectly positioned to exploit it.

"I am delighted that we have received approval to sell the Mologic ELISA antibody test in India as this is a key target market. We have an established direct sales team and we believe a reliable and high-performance antibody test will be very attractive to our laboratory customers. India is one of the fastest growing economies in the world and has a population of over 1.3 billion people. Clearly this is an important market for us to target and I look forward to updating shareholders on our commercial traction."

The current SP is only slightly higher than my first 29p buy when the company was focused on its existing portfolio of products. Now we have COVID, they are part of the consortium and have developed best in class products to combat it. They are funded and ready to move to the next stage with countries and governments as clients.

As far as AIM investments go this one has a lot of promise.

The end result is they have the money. Those that wanted the basic amount got them, those that wanted more than basic have something but maybe not their full request. I imagine they are the ones buying the stock at this price now.

Seems some might not get their desired amounts

"As applications under the Excess Application Facility cannot be satisfied in full, applications for New Ordinary Shares under the Excess Application Facility will be scaled back in accordance with the terms set out in the Circular."

Walbrook PR @WalbrookPR
15s
Omega Diagnostics Group plc (AIM: #ODX) @OmegaDiagnostic announces full take up of the Open Offer with funds to be deployed to exploit a range of COVID-19 testing opportunities and scale up manufacturing bit.ly/2Z60ydo

Hopefully one day they will do something other than disappointing us

Not letting you buy haha

Fully funded with gold standard products and ready to launch forward. Now let us get this share price where it should be and say goodbye to the sub 40p stock and 40p stock for that matter.

those sound like your broker put additional deadlines in place to give them time to facilitate the order.

The offer deadline was yesterday at 11am.

Yep fully funded and have the gold standard testing kit!!

Good to see this!

Morning all.